We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dezima Initiates Phase 2b TULIP Study on CETP Inhibitor Program DEZ-001

News   Aug 30, 2013

 
Dezima Initiates Phase 2b TULIP Study on CETP Inhibitor Program DEZ-001
 
 
 

RELATED ARTICLES

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

Urine Point-of-care Test Detects Antibiotic-resistant 'Superbugs'

News

A simple and inexpensive new test can diagnose patients with antibiotic-resistant strains of bacteria in a matter of minutes.

READ MORE

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE